Dissecting the pathways controlling tunable responses to TCR signaling
Dissecting the pathways controlling tunable responses to TCR signaling
批准号:
10314045
负责人:
LESLIE JOAN BERG
金额:
$47.89万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-24 至 2023-12-31
关键词:
ATAC-seqAffinityAllelesAntigensBehaviorBiochemicalBiological AssayCD8-Positive T-LymphocytesCalciumCategoriesCell physiologyCellsCellular Metabolic ProcessCessation of lifeChromatinChronicCytokine ReceptorsDataDoseEffector CellEquilibriumExhibitsGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGenetic TranscriptionHourIRF4 geneITAMImmediate-Early GenesImmune responseImmunityImmunotherapyImpairmentInfectionInfectious AgentKnock-inLeadLifeLinkListeria monocytogenesMemoryMicrobeMusNuclearOutcomeOvumPathogenicityPathway interactionsPatternPeptide/MHC ComplexPhosphorylationPopulationProcessProliferatingReceptor SignalingSecond Messenger SystemsSystemT cell differentiationT cell responseT-Cell ActivationT-Cell Activation PathwayT-Cell DevelopmentT-Cell ReceptorT-LymphocyteT-cell receptor repertoireTEC Protein Tyrosine KinaseTestingTranscriptional ActivationTransgenic MiceTyrosineUp-RegulationVariantVirus Diseasesanalogautoreactive T cellbasecancer therapycytokinedensitydigitalexperimental studyinsightmigrationpathogenphospholipase C gammaprogramsresponsesingle-cell RNA sequencingtherapeutically effectivethymocytetranscription factortranscriptome sequencingvaccinology
中文摘要
剖析控制TCR信号可调反应的途径
英文摘要
Dissecting the pathways controlling tunable responses to TCR signaling
Summary
Stimulation of the T-cell receptor (TCR) leads to activation, a process that includes changes in T cell
metabolism, survival, proliferation, cytokine responsiveness, migration behavior, and effector
functions. Life versus death, as well as lineage decisions of T cells are determined in large part by the
strength of TCR signaling. Our previous studies have demonstrated that the transcription factor IRF4
is upregulated by TCR stimulation in CD8 T cells, and that the maximum level of IRF4 achieved is
dependent on the strength of TCR signaling via the Tec kinase ITK. In turn, IRF4 promotes T cell
differentiation into massively proliferating antiviral effector cells in a dose-dependent manner. Yet,
mechanistic insight into how TCR stimulation produces a dynamic range of responses defined by
distinct gene expression patterns is currently lacking. Our preliminary studies indicate that the Tec
kinase ITK is a focal point for the tunable component of TCR signaling. Previous studies showed that
ITK is not required for all TCR signaling; instead, in its absence, TCR signaling is significantly
reduced. From these studies, the clear function of ITK was difficult to discern, as some aspects of T
cell activation appeared normal in the absence of ITK, whereas other T cell functions were greatly
impaired. Our current data, using IRF4 upregulation as an example of TCR tuning, provide a
framework to understand these apparent discrepancies. These studies have revealed that variations
in antigen density and in TCR affinity can modulate gene expression patterns shortly after activation
of naive CD8 T cells. Dissecting these pathways shows that the two second messengers generated
by activation of phospholipase C-γ, the major substrate of ITK, cooperate to regulate all-or-nothing
(digital) versus graded (analog) responses to changes in TCR signal strength. The relative balance
of these differing inputs determines which responses exhibit the broadest range of tunability to TCR
signaling. Based on these data, we hypothesize that the magnitude of ITK activity is determined by
the multiplicity of ITAM phosphorylation at the TCR, and that variations in ITK activity tune the
calcium response that regulates transcription factor activation. Further, we propose that ITK-
dependent tuning of TCR signal strength controls a program of gene expression that is established
within hours after TCR stimulation, and thus impacts the differentiation pathways of activated cells.
To test these hypotheses, we propose to determine how variations in TCR signal strength lead to
graded versus digital expression of entire programs of gene expression at the global and single cell
level, and how these patterns are established by the first wave of transcriptional activation following T
cell stimulation. We will also assess whether the magnitude of ITAM phosphorylation regulates the
dynamic range of ITK-dependent TCR signaling. Finally, we will examine whether the full dynamic
range of ITK-dependent TCR signaling is required to generate a broad repertoire of pathogen-
specific T cells that provide enhanced responses to variants of the primary infecting pathogen.
These experiments will provide important insights into the downstream consequences of alterations
in TCR signal strength, allowing a more informed approach to manipulating T cell activation pathways
for applications in the fields of vaccinology and immunotherapy.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/immunohorizons.1800032
发表时间:
2018-08-01
期刊:
ImmunoHorizons
影响因子:
--
作者:
[Gallagher, Michael P, Conley, James M, Berg, Leslie J]
通讯作者:
Berg, Leslie J
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10531600
-
项目类别:
-
资助金额:$57.71万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10307579
-
项目类别:
-
资助金额:$57.89万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:10064991
-
项目类别:
-
资助金额:$58.04万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
TCR signaling control of thymic Treg selection and immune homeostasis
-
批准号:9887472
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2019
-
负责人:LESLIE JOAN BERG
-
依托单位:
Dissecting the pathways controlling tunable responses to TCR signaling
-
批准号:10074912
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2018
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8498675
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8664794
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Plasticity of T helper cell differentiation
-
批准号:8833242
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2013
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8317595
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8190000
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8516976
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
FASEB SRC on Signal Transduction in the Immune System
-
批准号:8129134
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8386936
-
项目类别:
-
资助金额:$53.33万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8204398
-
项目类别:
-
资助金额:$56.73万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
Regulation of conventional versus innate CD8+ T cell development
-
批准号:8041181
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8581295
-
项目类别:
-
资助金额:$56.73万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
ITK: an emerging target for treatment of T cell-mediated autoimmune disease
-
批准号:8042232
-
项目类别:
-
资助金额:$56.75万
-
财政年份:2010
-
负责人:LESLIE JOAN BERG
-
依托单位:
Tec Kinases ltk and RlK in Mast Cell Signaling
-
批准号:7371047
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2006
-
负责人:LESLIE JOAN BERG
-
依托单位:
Tec Kinases ltk and RlK in Mast Cell Signaling
-
批准号:7098577
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2006
-
负责人:LESLIE JOAN BERG
-
依托单位:
Tec Kinases ltk and RlK in Mast Cell Signaling
-
批准号:7584041
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2006
-
负责人:LESLIE JOAN BERG
-
依托单位:
海外基金